Creon After Pancreatic Surgery
- Registration Number
- NCT00535756
- Lead Sponsor
- Abbott Products
- Brief Summary
This study will provide efficacy data for Creon 25000 MMS in PS patients as well as long-term safety data. During the long-term treatment with Creon 25000 nutritional parameters will be assessed and correlated with CFA
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 58
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 2 Placebo - 1 Creon -
- Primary Outcome Measures
Name Time Method Change in CFA from baseline to the end of double blind treatment 7 days after baseline
- Secondary Outcome Measures
Name Time Method CNA, stool fat, stool weight, nutritional parameters, clinical symptomatology, SF-36, BMI 7 days after baseline, and end of open-label period (1 year of open label treatment)
Trial Locations
- Locations (15)
Site Reference ID/Investigator# 45020
๐ง๐ฌSofia, Bulgaria
Site Reference ID/Investigator# 45024
๐ฉ๐ชMunich, Germany
Site Reference ID/Investigator# 45130
๐ฎ๐นBologna, Italy
Site Reference ID/Investigator# 45128
๐ฎ๐นVerona, Italy
Site Reference ID/Investigator# 45022
๐ง๐ฌRuse, Bulgaria
Site Reference ID/Investigator# 45129
๐ฎ๐นPadova, Italy
Site Reference ID/Investigator# 45027
๐ฉ๐ชHeidelberg, Germany
Site Reference ID/Investigator# 45025
๐ฉ๐ชHamburg, Germany
Site Reference ID/Investigator# 45126
๐ญ๐บBekescsaba, Hungary
Site Reference ID/Investigator# 45121
๐ญ๐บBudaors, Hungary
Site Reference ID/Investigator# 45115
๐ญ๐บGyula, Hungary
Site Reference ID/Investigator# 45116
๐ญ๐บSopron, Hungary
Site Reference ID/Investigator# 45127
๐ญ๐บDunaujvaros, Hungary
Site Reference ID/Investigator# 45114
๐ญ๐บSzeged, Hungary
Site Reference ID/Investigator# 45026
๐ฉ๐ชGreifswald, Germany